Treatment Recommendation for 1.6 cm Upper Ureteral Stone
Ureteroscopy (URS) is the gold standard treatment for this 1.6 cm upper ureteral obstructive stone with 500 HU density, and it should be performed over ESWL. 1
Rationale for Ureteroscopy Over ESWL
Stone Characteristics Favor URS
Stone size of 1.6 cm (16 mm) significantly reduces ESWL success rates. The 2025 EAU guidelines indicate that URS is increasingly favored for ureteral stones, particularly with technical advances in flexible ureteroscopy 1. For stones >15 mm in the proximal ureter, percutaneous antegrade URS is specifically mentioned as an option, highlighting that large upper ureteral stones are challenging for ESWL 1.
The stone density of 500 HU predicts ESWL failure. Research demonstrates that mean stone density >900 HU significantly reduces ESWL success (OR = 0.49), but even at 500 HU, this is a moderately dense stone that will resist fragmentation 2. Stone size >5 mm in the proximal two-thirds of the ureter correlates with need for endoscopic intervention 3.
Upper ureteral location is problematic for ESWL. Historical data shows that while "all stones in the upper third of the ureter are preferably treated by ESWL," this was based on smaller stones 4. Modern guidelines recognize that URS has become the preferred approach with improved technology 1.
Clinical Context Supports Immediate Intervention
Moderate hydronephrosis with perinephric fat stranding indicates significant obstruction. While perinephric stranding alone doesn't mandate immediate intervention 5, the combination with moderate hydronephrosis and a large obstructing stone warrants definitive treatment rather than observation 6.
The presence of additional 3 mm calyceal stones can be addressed simultaneously with URS. During flexible ureteroscopy for the ureteral stone, the surgeon can access the renal collecting system and treat the 3 mm middle calyceal stones in the same procedure, achieving complete stone clearance 1.
ESWL Limitations in This Case
ESWL success rates decline dramatically with stones >10 mm. In pediatric populations (where data is clearest), stone-free rates drop to 73% for stones >10 mm versus 87% for stones <10 mm 1. Adult data shows similar trends with success rates of 60-90% overall, but this includes predominantly smaller stones 2.
Risk of steinstrasse is 4% with ESWL, which would be particularly problematic with a 1.6 cm stone fragmenting in the upper ureter 1.
ESWL requires proper acoustic coupling and may need multiple sessions for a stone this size, increasing cumulative morbidity and delaying definitive treatment 1.
Recommended Treatment Algorithm
Primary Treatment: Ureteroscopy with Laser Lithotripsy
Perform flexible or semirigid URS with holmium:YAG or thulium fiber laser lithotripsy for the 1.6 cm upper ureteral stone 1.
Complete stone removal is the goal; "dust and go" should be limited to large renal stones, not ureteral stones 1.
Address the 3 mm middle calyceal stones during the same procedure if flexible ureteroscopy is used, as these are accessible and can be treated with laser lithotripsy 1.
Perioperative Considerations
Routine pre-stenting is not required but may improve treatment outcomes for accessing renal stones 1.
Post-URS stenting is unnecessary after uncomplicated procedures, though it should be considered if there is trauma, residual fragments, bleeding, or perforation 1.
Prescribe alpha-blockers post-operatively if a stent is placed to improve tolerability, and consider medical expulsive therapy (MET) to aid passage of any small residual fragments 1.
Antibiotic Prophylaxis
- Tailor antibiotic prophylaxis to institutional resistance patterns 1. URS is classified as a low-risk bleeding procedure, unlike ESWL which is high-risk 1.
Common Pitfalls to Avoid
Do not attempt ESWL first for this large, dense upper ureteral stone. The combination of size (16 mm), density (500 HU), and location makes primary ESWL success unlikely, and failure would delay definitive treatment while the kidney remains obstructed 2, 3.
Do not ignore the additional calyceal stones. While they are non-obstructive now, addressing them during URS prevents future symptomatic episodes 1.
Do not perform "blind" instrumentation or consider open ureteral lithotomy, as these approaches are no longer justified 4.